163 related articles for article (PubMed ID: 38782602)
1. A consensus molecular subtypes classification strategy for clinical colorectal cancer tissues.
de Back TR; Wu T; Schafrat PJ; Ten Hoorn S; Tan M; He L; van Hooff SR; Koster J; Nijman LE; Vink GR; Beumer IJ; Elbers CC; Lenos KJ; Sommeijer DW; Wang X; Vermeulen L
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38782602
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.
Morris JS; Luthra R; Liu Y; Duose DY; Lee W; Reddy NG; Windham J; Chen H; Tong Z; Zhang B; Wei W; Ganiraju M; Broom BM; Alvarez HA; Mejia A; Veeranki O; Routbort MJ; Morris VK; Overman MJ; Menter D; Katkhuda R; Wistuba II; Davis JS; Kopetz S; Maru DM
Clin Cancer Res; 2021 Jan; 27(1):120-130. PubMed ID: 33109741
[TBL] [Abstract][Full Text] [Related]
3. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
Stintzing S; Wirapati P; Lenz HJ; Neureiter D; Fischer von Weikersthal L; Decker T; Kiani A; Kaiser F; Al-Batran S; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Moehler M; Scheithauer W; Held S; Modest DP; Jung A; Kirchner T; Aderka D; Tejpar S; Heinemann V
Ann Oncol; 2019 Nov; 30(11):1796-1803. PubMed ID: 31868905
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue.
Jovanović B; Sheng Q; Seitz RS; Lawrence KD; Morris SW; Thomas LR; Hout DR; Schweitzer BL; Guo Y; Pietenpol JA; Lehmann BD
BMC Cancer; 2017 Apr; 17(1):241. PubMed ID: 28376728
[TBL] [Abstract][Full Text] [Related]
5. Robust transcriptional tumor signatures applicable to both formalin-fixed paraffin-embedded and fresh-frozen samples.
Chen R; Guan Q; Cheng J; He J; Liu H; Cai H; Hong G; Zhang J; Li N; Ao L; Guo Z
Oncotarget; 2017 Jan; 8(4):6652-6662. PubMed ID: 28036264
[TBL] [Abstract][Full Text] [Related]
6. 72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.
Nishio M; Naoi Y; Tsunashima R; Nakauchi C; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
Clin Breast Cancer; 2014 Jun; 14(3):e73-80. PubMed ID: 24461457
[TBL] [Abstract][Full Text] [Related]
7. Gene-expression analysis of a colorectal cancer-specific discriminatory transcript set on formalin-fixed, paraffin-embedded (FFPE) tissue samples.
Kalmár A; Wichmann B; Galamb O; Spisák S; Tóth K; Leiszter K; Nielsen BS; Barták BK; Tulassay Z; Molnár B
Diagn Pathol; 2015 Jul; 10():126. PubMed ID: 26208990
[TBL] [Abstract][Full Text] [Related]
8. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
[TBL] [Abstract][Full Text] [Related]
9. Consensus molecular subtype classification of colorectal adenomas.
Komor MA; Bosch LJ; Bounova G; Bolijn AS; Delis-van Diemen PM; Rausch C; Hoogstrate Y; Stubbs AP; de Jong M; Jenster G; van Grieken NC; Carvalho B; Wessels LF; Jimenez CR; Fijneman RJ; Meijer GA;
J Pathol; 2018 Nov; 246(3):266-276. PubMed ID: 29968252
[TBL] [Abstract][Full Text] [Related]
10. A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
Piskol R; Huw L; Sergin I; Kljin C; Modrusan Z; Kim D; Kljavin N; Tam R; Patel R; Burton J; Penuel E; Qu X; Koeppen H; Sumiyoshi T; de Sauvage F; Lackner MR; de Sousa E Melo F; Kabbarah O
Clin Cancer Res; 2019 Jul; 25(14):4431-4442. PubMed ID: 31004000
[TBL] [Abstract][Full Text] [Related]
11. MethCORR modelling of methylomes from formalin-fixed paraffin-embedded tissue enables characterization and prognostication of colorectal cancer.
Mattesen TB; Rasmussen MH; Sandoval J; Ongen H; Árnadóttir SS; Gladov J; Martinez-Cardus A; Castro de Moura M; Madsen AH; Laurberg S; Dermitzakis ET; Esteller M; Andersen CL; Bramsen JB
Nat Commun; 2020 Apr; 11(1):2025. PubMed ID: 32332866
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer.
Omolo B; Yang M; Lo FY; Schell MJ; Austin S; Howard K; Madan A; Yeatman TJ
BMC Med Genomics; 2016 Oct; 9(1):65. PubMed ID: 27756306
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue.
Mittempergher L; de Ronde JJ; Nieuwland M; Kerkhoven RM; Simon I; Rutgers EJ; Wessels LF; Van't Veer LJ
PLoS One; 2011 Feb; 6(2):e17163. PubMed ID: 21347257
[TBL] [Abstract][Full Text] [Related]
14. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY
Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
[TBL] [Abstract][Full Text] [Related]
16. Gene expression profiles of gliomas in formalin-fixed paraffin-embedded material.
Gravendeel LA; de Rooi JJ; Eilers PH; van den Bent MJ; Sillevis Smitt PA; French PJ
Br J Cancer; 2012 Jan; 106(3):538-45. PubMed ID: 22187034
[TBL] [Abstract][Full Text] [Related]
17. Analyses and interpretation of whole-genome gene expression from formalin-fixed paraffin-embedded tissue: an illustration with breast cancer tissues.
Kibriya MG; Jasmine F; Roy S; Paul-Brutus RM; Argos M; Ahsan H
BMC Genomics; 2010 Nov; 11():622. PubMed ID: 21059268
[TBL] [Abstract][Full Text] [Related]
18. Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes.
Ragulan C; Eason K; Fontana E; Nyamundanda G; Tarazona N; Patil Y; Poudel P; Lawlor RT; Del Rio M; Koo SL; Tan WS; Sclafani F; Begum R; Teixeira Mendes LS; Martineau P; Scarpa A; Cervantes A; Tan IB; Cunningham D; Sadanandam A
Sci Rep; 2019 May; 9(1):7665. PubMed ID: 31113981
[TBL] [Abstract][Full Text] [Related]
19. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
[TBL] [Abstract][Full Text] [Related]
20. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
